行业政策与环境 医药生物行业在人口老龄化和政策支持下具备长期发展潜力，但个股表现可能受到行业政策动态及公司 自身研发投入等因素的影响。 资金面情况 数据显示，2026年1月7日，公司主力资金净流入207.40万元，较前一交易日由净流出转为净流入，显示 短期市场情绪可能有所转强。此前1月5日也曾出现主力资金净流入的情况。 公司基本面 2025年前三季度，公司实现营收4.81亿元，归母净利润9190万元，同比有所下降。投资者可关注后续定 期财务报告的发布。 经济观察网新天地（301277）近期在产品研发和资金面方面有动态更新。 产品研发进展 公司抗流感病毒在研产品磷酸奥司他韦原料药及胶囊正按计划推进。此外，其富马酸亚铁原料药已于 2025年12月获批上市，用于预防和治疗缺铁性贫血，丰富了产品管线。 以上内容基于公开资料整理，不构成投资建议。 ...

Core Insights - The Hefei-Xin High-Speed Railway's Hefei-Su segment has successfully transported over 150,000 passengers in its first month, averaging nearly 5,000 passengers daily, significantly enhancing regional connectivity and economic development [1][2] Group 1: Economic Impact - The railway has established five stations, creating a "1-3 hour transportation circle" connecting Hefei, Nanjing, and Shanghai, transforming the eastern Anhui region from a "provincial edge" to a "strategic node" [1] - The reduction in travel time has accelerated the flow of production factors, evidenced by nearly 10,000 passengers during peak travel days, including students, workers, investors, and tourists [1] Group 2: Industry Development - Local governments are leveraging the railway to convert "transit dividends" into "industrial dividends," with initiatives like transporting local products such as Tuo Lake crabs and developing themed tourism routes [2] - The integration of "railway + culture and tourism" and "railway + agriculture" is facilitating the transformation of passenger flow into commercial and financial flows, demonstrating the railway's potential as a lever for industrial upgrading and rural revitalization [2] Group 3: Regional Integration - The Hefei-Xin High-Speed Railway exemplifies the national strategy of Yangtze River Delta integration, showcasing a "feedback effect" where capital, passenger flow, and technology are shared and transferred towards eastern Anhui [2] - The railway promotes a model of regional cooperation where the flow of resources leads to a reduction in regional disparities, fostering a more integrated economic landscape [2]

回到焕河村，丁浪创办电商公司，借着短视频风口，带着让大山美好被看见的初心，运营起黔东农仓、 爱莲嬢嬢等新媒体账号。没有华丽的特效，没有刻意的剧本，只有山间的清风、田埂的烟火、老乡的淳 朴，这些最本真的乡村模样，反而戳中了无数人的心，让他收获近500万粉丝，也为小山村插上了数字 翅膀。 记者：颜烨 一审：王琰 二审：何天洋 三审：王玺 "乡村不是退路，而是新的赛道。"这话，是贵州省政协委员丁浪用青春和实干，在大山深处写下的答 案。 丁浪没有止步于短视频引流，而是顺势开启直播助农，让镜头成为连接大山与市场的桥梁。一份份农特 产品通过屏幕走出贵州，累计销售额突破5000万元；一个个家门口的就业岗位应运而生，50多位村民实 现了"顾家赚钱两不误"。 对不少乡村青年来说，故乡常常被视作闯荡失败后的"退路"。但丁浪不同，他在大学毕业后主动选择回 到年轻人外流严重、只剩老幼守望的老家——德江县焕河村。在他眼里，乡村从不是无奈的兜底，而是 藏着无限可能的新赛场。 丁浪的故事告诉我们，所谓赛道，从来不是固定的轨道，而是敢于突破常规的勇气；所谓成功，只不过 是扎根一方、深耕细作的坚持。乡村从不是落后的代名词和无奈时的退路，而是待 ...

（文章来源：每日经济新闻） 新天地（301277.SZ）1月28日在投资者互动平台表示，公司暂无抗流感病毒中间体医药产品。公司抗流 感病毒领域在研产品磷酸奥司他韦原料药、磷酸奥司他韦胶囊正在按计划开展中。 每经AI快讯，有投资者在投资者互动平台提问：公司的抗病毒流感医药中间体可以介绍一下吗？ ...

Core Viewpoint - The company, Xintiandi (301277.SZ), has stated that it currently does not have any intermediate pharmaceutical products for antiviral flu treatment, but is progressing with its research products, including Oseltamivir phosphate raw materials and Oseltamivir phosphate capsules, as planned [1]. Group 1 - The company has no antiviral flu intermediate pharmaceutical products available at this time [1] - The research products in the antiviral flu field include Oseltamivir phosphate raw materials and Oseltamivir phosphate capsules [1] - The development of these products is proceeding according to schedule [1]

Core Viewpoint - The company, Xintiandi (301277.SZ), has stated that it currently does not have any intermediate pharmaceutical products for antiviral flu treatment, but is progressing with its research products, including Oseltamivir phosphate raw materials and Oseltamivir phosphate capsules, as planned [1] Group 1 - The company has no antiviral flu intermediate pharmaceutical products available at this time [1] - The research products in the antiviral flu field include Oseltamivir phosphate raw materials and Oseltamivir phosphate capsules [1] - The development of these products is proceeding according to schedule [1]

Group 1 - The company, Xintiandi (301277.SZ), stated on the investor interaction platform that it currently has no nucleoside (acid) raw materials [1]

□四川日报全媒体记者 文露敏 高杲 李强"十四五"时期建设西部地区创新高地的"四川步伐" 综合创新能力稳步提升 ●全省研发经费投入预计达到1500亿元左右，比2020年增长40%以上 ●技术合同成交额突破2600亿元，比2020年翻了一番 ●全省高新技术产业营业收入占规上工业比重由2020年的31.9%提高到40.9% 高能级创新平台加快建设 ●在川国家级创新平台增至205个，包括西部唯一的国家实验室、28个全国重点实验室、4个国家级创新中心 ●加快建设10个国家大科学装置 关键核心技术取得重大突破 创新主体活力持续迸发 产业体系进一步优化 ●聚集17条重点产业链建圈强链，布局25条产业新赛道，加快培育新兴产业及未来产业 ●人工智能、无人机等重点领域保持两位数以上增长 是当技术"大咖"，还是去当"销冠"？这是个问题。 2024年，身为布法罗机器人科技（成都）有限公司（下称布法罗）技术负责人的蒋相春下定决心，转到销售岗 位，"自己研发的产品自己推广。"如今，担任公司去年成立的家用事业部副总经理的他，更是研发、销售两手 抓。 布法罗研制的下肢步行外骨骼机器人，2017年获吴文俊人工智能科学技术进步奖一等奖，201 ...

Group 1 - The core viewpoint of the news is that Xintiandi Pharmaceutical Co., Ltd. has shown fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks [1][2]. Group 2 - On January 26, Xintiandi's stock rose by 1.39%, with a trading volume of 68.41 million yuan. The margin trading data shows a net buying of 2.13 million yuan for that day [1]. - As of January 26, the total margin trading balance for Xintiandi was 95.42 million yuan, which is 1.86% of its market capitalization and below the 50th percentile level over the past year, indicating a low level of margin financing [1]. - In terms of short selling, on January 26, Xintiandi had no shares sold short, with a short selling balance of 0.00 yuan, which is at a high level compared to the 80th percentile over the past year [1]. Group 3 - As of December 19, the number of shareholders for Xintiandi was 17,900, a decrease of 2.02% from the previous period, while the average circulating shares per person increased by 2.06% to 21,856 shares [2]. - For the period from January to September 2025, Xintiandi reported a revenue of 481 million yuan, a year-on-year decrease of 10.42%, and a net profit attributable to shareholders of 91.90 million yuan, down 35.19% year-on-year [2]. - Since its A-share listing, Xintiandi has distributed a total of 259 million yuan in dividends [2].

省人大代表、西安爱菊粮油工业集团董事长贾合义 省政协委员、长安大学经济与管理学院副院长樊建强 开放平台提质增效。陕西自贸试验区形成一批可复制推广的制度创新成果。上合组织农业技术交流培训 示范基地建设扎实推进。综合保税区、跨境电商综试区等平台支撑作用增强。 制度型开放探索深化。陕西深入开展营商环境突破年活动，"放管服"改革持续深化；在投资贸易便利 化、金融开放创新、人才引进等领域进行有益尝试，市场化、法治化、国际化一流营商环境加快构建。 产业开放协同加强。陕西围绕半导体、新能源汽车等重点产业链引进外资和龙头企业取得进展，本土企 业"走出去"步伐加快，内外资融合发展的产业生态正在形成。 问："十五五"时期，陕西应以怎样的思路推动内陆改革开放向纵深发展？ 樊建强："十五五"时期，陕西应以更大魄力推动内陆改革开放向纵深发展。 一是打造"双循环"战略枢纽示范。推动中欧班列西安集结中心从"通道经济"向"枢纽经济"全面升级。强 化空港、陆港协同，建设面向"一带一路"的供应链组织与商贸物流中心。 问："十四五"期间，陕西打造内陆改革开放高地取得了哪些阶段性成效？ 樊建强："十四五"以来，陕西紧扣高质量发展主题，全力打造内陆改 ...